U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07214454) titled 'TCDS for the Treatment of Chronic Migraine' on Sept. 30.
Brief Summary: Migraine affects 1 in 7 people worldwide, but for those suffering from chronic migraine there is a need for safe, effective and well tolerated treatments. The Nettle device is a non-invasive device, which is worn like a headband and delivers electrical stimulation (known as transcranial direct current stimulation or TCDS) to areas of the brain known to be involved in the processing of pain. In this study, 20 patients will be trained on how to use the device and then use it daily at home for 20 minutes for three months. Patients will complete a headache diary and...